FDA Inspection
Sant P. Chawla, MDSant P. Chawla, MD – FDA Inspection, Jun 30, 2026
Record Details
This FDA Inspection record concerns Sant P. Chawla, MD, with an inspection on June 30, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · 3c3a42fe-8e34-4a8b-8a5c-0b64111ab2b9
Inspection Facts
- Inspection number
- 1324454
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sant P. Chawla, MD
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 15, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 13, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 13, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 30, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 29, 2011 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sant P. Chawla, MD
- FDA Inspection 1167324 - 2022-04-15
- FDA Inspection 945678 - 2015-10-13
- FDA Inspection 757044 - 2011-12-13
- FDA Inspection 757043 - 2011-11-30
- FDA Inspection 722028 - 2011-04-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.